Showing posts with label Menactra. Show all posts
Showing posts with label Menactra. Show all posts

Monday, September 13, 2010

Gardasil and seizures: is VAERS now taking a connection seriously?

Share
Theresa E was floored when she got a phone call from VAERS, the FDA’s vaccine adverse event reporting system. Yes, the caller said, investigators did indeed feel that Theresa’s daughter’s seizures could be a serious reaction to Merck’s anti-HPV vaccine, Gardasil.

Although Theresa had had a hunch that her daughter’s intermittent seizures could have been triggered by the Gardasil vaccine, doctors completely pooh-poohed the idea.

But eventually, encouraged by information from Nina Kenney, whose daughter had also begun suffering seizures post-vaccine, she insisted on filing a VAERS report. Her doctor had for months been “too busy” to get around to the paperwork, she said, “and when I took the almost-completed form to him to finish he was a little shocked that I was serious.”

So when someone from VAERS called shortly afterwards to verify the information she’d provided and made the comment about a serious reaction, Theresa was so stunned that she asked her caller to repeat it. She’s relieved to see that taking the time to report to VAERS was worthwhile; her information will add to what investigators know.

Yes, report post-vaccine seizures—even if your doctor discourages you

"If I can prevent one more person from getting hurt, it’s all worth it. Please encourage people to send as much concrete information to VAERS as possible, because I think that’s why they listened. I didn’t just send the form. There isn’t enough space on the form to give much info, so they got a two-page letter, copies of the school report about where they found my daughter and letters stating that the (Gardasil) vaccines were stored improperly. I felt I was sending too much info, but I am glad I did. Whether it is an active ingredient or an inactive ingredient, they need to find out for sure.”

None of this is to say that there is now a proven connection between Gardasil and seizures: there isn’t, or at least, not at this point. Teenagers do develop epilepsy and seizure disorders with or without Gardasil. But when seizures follow vaccination in multiple cases, medical investigators need to—well, investigate. That’s what the FDA is supposed to do. And, thank God, they’re now doing it.

Do neurologists ask about pre-seizure vaccinations yet?

In February 2009, Gardasil vaccinations were briefly suspended in Spain after three unrelated incidents in which girls began suffering repeated convulsions hours after being vaccinated with the HPV vaccine. Eventually, authorities determined that the vaccine might have triggered, but not caused, the convulsions—a distinction that still eludes me in practical terms—largely because there were few similar cases on the books. (See here). With the best will in the world, investigators can’t reconcile correlation and causation without enough data. So just make the reports, already.

After a young girl, Jenny Tetlock, died post-Gardasil vaccination from a highly unusual ALS/autoimmune-type disease mediated by immune response, her neurologist, knowing of at least one similar case, announced to fellow neurologists that she planned to make a study of girls with ALS-type diseases (see here). Finding any such cases requires that neurologists make a habit of asking patients whether they got the vaccine.

There are so many cases of post-Gardasil seizures that surely it would be smart to call on neurologists seeing new seizure patients to ask them that question, too. Just ask the question—did you get Gardasil? Menactra? Adacel? Together or separately?—and file any appropriates reports with VAERS. Then, if there’s a connection, we’ll know.

Theresa’s daughter got her first Gardasil shot, along with Menactra, in July 2009. She suffered a commotion-causing ‘sleepwalking’ episode in her dorm in August and a second episode after the second shot. Theresa believes that both episodes were really seizures as her daughter was disoriented and appeared to observers to be on drugs; the second time the teenager recalls feeling twitchy and exhausted (common post-seizure symptoms) afterwards. Then her parents actually witnessed her seizing while they were all on vacation. The experience was devastating, but at least they finally knew was wrong. Now in her second year of college, she’s been diagnosed with a nocturnal seizure disorder and is taking Keppra twice daily.

Drugged, drunk—or seizing?

The drugged appearance is all too familiar to Nina. “I’ve never seen Nora seize, but a few weeks ago I saw her right after a seizure. She was extremely disoriented, and in fact I thought she was drunk. She was very perturbed as well. Flat out mean. She tells me this behavior is a common factor with her seizures. She has yelled at paramedics and anyone who's nearby right afterward. Furthermore, she has no memory of the seizure and often, the entire day leading up to the seizure. Post seizure, she's exhausted and has a terrible headache for a day or two afterward.”

When Theresa witnessed her daughter’s seizure on vacation, “our daughter did appear to be drunk or really out of it; she could not correctly answer the questions for paramedics after the seizure. After a bit, she did.”

Which makes one wonder whether some seizures go undiagnosed because the usual reaction to a young adult who appears to be drunk or drugged is an eye-rolling “kids will be kids.”

“As far as the MRI and EEG,” says Nina, “Nora's MRI and CT scan have been normal. She's only had one EEG and, according to the first neurologist she saw, it showed a 'slight abnormality'. I think he used the term compact partial seizure.”

The ER doctor’s diagnosis after Nora’s first seizure was syncope/dehydration because he attributed the episode to alcohol consumption the day before—even though the episode included severe tongue-biting, “a classic seizure symptom,” according to the neurologist Nora later saw. When she seized again after her second Gardasil shot, however, the final diagnosis was Epileptic Seizures, and her VAERS report now shows it as a “positive vaccine re-challenge”—which basically means that the same symptoms, or worse symptoms, presented themselves with the second shot, making a connection highly plausible. Nora did not get the third shot.

Two girls, two different VAERS responses, two years apart

Nina had a very different experience with reporting Nora’s seizures to VAERS two years ago.

When she made the connection between Gardasil and Nora’s seizures, she faxed a letter to Nora’s neurologist, sent another to the pediatrician, filed an online VAERS report, called Merck, filed an online report with Sanofli-Pasteur (because Nora had also received a Menactra shot with her first Gardasil shot), and filed an online report with the NVIC. Only the NVIC and the pediatrician responded.

A few months later, Emily Tarsell, whose daughter Chris died of still-unknown causes after receiving the Gardasil vaccination, suggested that Nina contact the FDA for the Gardasil lot numbers and reports. When the reports arrived, Nina discovered that Nora’s VAERS report seemed to include Nora among the girls who fainted upon getting the shot, probably because of the ER report after the first episode. She immediately faxed VAERS a letter; they contacted her only to get her neurologist’s contact information and left the report essentially unchanged.

Only after Nina sent a strongly-worded letter to the Vaccines and Related Biological Products Advisory Committee, prior to their meeting to decide whether to approve Gardasil for boys, did VAERS actually contact her for a timeline of events and further information. Nina’s letter had commented that a year after she’d made all those reports, no-one had bothered to contact her. Two weeks later, she heard from VAERS. After an entire year.

It bears repeating: Gardasil is not proven to cause seizures in susceptible individuals. If you're considering Gardasil for yourself of your child, you and your doctor need to honestly discuss its pros and cons given your individual circumstances and family health history.

But, “I subscribe to the Epilepsy Foundation site's parent community,” says Nina, “and there are MANY members whose seizures started after Gardasil. So in spite of what most in the medical community say, I believe there's a connection.”

And it appears that if there is one, the FDA's finally started seriously looking for it. So do your part. If your child's seizures began only after an adolescent vaccination of any kind, file the report. With or without the help and/or encouragement of your doctor.

© 2010 www.gardasilhpv.com

Permission is freely given to accurately reproduce the first five paragraphs of this article, along with a link back to this site and the entirety of the article.

Thursday, September 10, 2009

Will Your Son Get the Gardasil Vaccine?

Share
Now that the FDA’s vaccine advisory panel has given the nod to Gardasil for boys and men, the FDA is almost certain to approve the new market.

Although several panel members expressed concerns about the unknown duration of Gardasil’s protection against four strains of the HPV virus, only one member voted no. That was Vicky Debold, PhD, RN, who is the panel’s consumer representative.

"It would be a mistake to go forward and recommend that boys be encouraged to take this vaccine,” Dr. Debold said, “until we understand what's going on with the safety issues that [are] cropping up in girls.”

The value and safety of Gardasil have been increasingly questioned of late, notably this month in JAMA. The FDA has warned that the vaccine demonstrably raises the risk of syncope and blood clots, although it believes that the potential benefits far outweigh the risks. Drs. Sheila and David Rothman noted in JAMA that there was no data available about the vaccine’s effect on natural immunity, replacement diseases, or human behavior, such as ditching annual exams. They questioned the assumption that defeating HPV strains 16 and 18 will lead to a marked reduction in cases of cervical cancer. And they expressed concern that consumers were pushed to get the vaccine without being given the unbiased information necessary to properly weigh risks versus benefits.

Meanwhile, the vaccine has been associated with various serious side effects, including neurological and autoimmune conditions, in a small percentage of girls who’ve received one or more doses of the vaccine. No link, however, has been demonstrated at this point. (On the bright side for the parents of boys, autoimmune disease, which can be triggered in susceptible individuals by environmental factors, is less common in males than in females.)

“I would love my daughter and my son to get a vaccination that would prevent any kind of HPV, but it has to be at no cost, and I don't mean financial cost, I mean at no health risk cost," Dr. Jacques Moritz, the director of gynecology at St Luke's Roosevelt Hospital, told CBS news.

For boys, the vaccine has fewer potential direct benefits than for girls. The FDA was asked to consider only its efficacy for preventing genital warts, which affect about one percent of the population. Although the human papillomavirus can cause anal, penile, perineal and oral cancers in men, such cancers are very rare and are not as directly traceable to HPV—only about 40 percent of penile cancers, for instance, are related to HPV. Many boys and men will get the vaccine mostly as a way of protecting future partners. That gesture that can only be applauded by any woman.

As always, parents need to educate themselves about risks and benefits and honestly assess their individual lifestyles and family histories. One would expect the parent of a child with any family or personal history of autoimmune disease to be particularly cautious. On the other hand, an individual or the parent of a child with a lifestyle known to strongly increase incidence of persistent HPV infection—a poor diet including few fruits and vegetables, a smoking habit, many sexual partners, frequent sleep deprivation, lousy hygiene habits—might be more enthusiastic about the vaccine and less concerned about possible side effects. Males should also know that not being circumcised also substantially raises the risk of both transient and persistent HPV infections. Even a transient infection (some 95 percent of HPV infections are simply shrugged off, virtually always leaving behind natural immunity to that particular strain) can cause a persistent infection in a partner.

We are, hopefully, long past the days when we assume that what’s good for one person (or many) is good for every individual. In the case of Gardasil, none of the available choices are risk-free.

So what do you think? Will you as parents be getting Gardasil for your sons, and will men be getting it for themselves?

Monday, August 3, 2009

Actually, the Feds DIDN’T Say Gardasil Causes 400 Percent more Deaths

Share
When you question a vaccine, whether as a parent, researcher, doctor or writer, you automatically get put in the “crazy” camp. And it doesn’t help when there are people out there misreporting facts and misattributing information.

I’m quite sure I don’t get everything right, but if I don’t, it’s not for want of fact-checking to the very best of my ability. So it made me nuts watching an error-ridden article mushroom across the web last week. The story was about how the feds have concluded that Gardasil causes 400 percent more deaths than the meningococcal vaccine Menactra, and it immediately rang alarm bells for anyone who tries to keep up properly with the unfolding Gardasil side-effects story.

Forensic tracking (not that hard; it was quoted as the entire source for the article) took me back to a New Zealand pro-life blog’s mistake. Back in March, familylifenz posted, “A new report, issued in February, by the centralized federal Vaccine Adverse Events Reporting System in the United States, has compared the anti-HPV vaccine Garasil, with the Menactra (meningococcal) vaccine, and it has found that Gardasil is associated with a far high rate of serious adverse effects than Menactra is.”

One staffer for a natural health site somewhat belatedly picked up on this and apparently followed the provided link back to the report itself for the 400 percent statistic but didn’t notice that it was, in fact, issued by the National Vaccine Information Center, not VAERS. The NVIC isn’t a federal agency, it’s an organization founded by parents whose children have been damaged by vaccines.

The NVIC’s very useful report analyzed data about Menactra and Gardasil from the VAERS system and made some recommendations to the CDC, the FDA, and Congress. It did indeed note that Gardasil was associated with four times as many deaths (and with even greater increases in other adverse events) as Menactra. To say, however, that “a federal report” came to that conclusion, and that researchers for VAERS had commented on the unusually high death rate, is—well, flat-out wrong.

No beef with the NVIC. I thought the report was interesting and blogged about it back when they issued it.

“I am all about the Gardasil vs. Menactra stat as it lives in my house,” wrote one reader to me just yesterday. “I have three kids who all had doctor appointments last June 16, 2008. All three got Menactra; only Nora got Gardasil too, and she was the only one to end up in the ER 5 days later. And again 20 days after her second shot.” Her daughter has been on anti-seizure medication ever since; and she's far from the only girl who has suffered seizure problems after getting the vaccine.

There are obvious pitfalls to the report on the passive VAERS system, of course, as vaccine side-effects are both under-reported and over-reported, and any scientist will quickly point out that correlation doesn’t equal causality. And the CDC isn’t one whit alarmed by the numbers of Gardasil-related adverse events because—even at four or more times the rate of those related to Menactra—in the context of multiple millions of doses given, they’re statistically insignificant (unless you’re a victim or the parent of one, naturally) and it’s statistics that ring alarm bells.

I don’t much like Gardasil. To me it seems rather ineffective, likely to cause replacement disease and highly suspect as a trigger for a variety of auto-immune diseases in susceptible individuals; and Merck’s marketing tactics, what with fake medical journals and doctor-discrediting “hit lists,” are frankly shocking for even the most cynical among us. Unless something happens to change my mind, I’m not getting Gardasil for either of my own daughters.

But when I see an erroneous story being picked up and regurgitated without question on multiple sites and blogs, it is just infuriating. Pretty soon it will have gained the same “everyone knows” status as that canard about how the CDC “knows” that HPV doesn’t cause cervical cancer.

It’s quite possible, even probable, that there’s real harm being done with HPV vaccines. And yet there are careless people out there are making damaged girls and their parents look like credulous crazies. Please, check facts.

Wednesday, July 15, 2009

So Why ARE Gardasil Girls Suffering Fainting and Syncope?

Share
You knew it would happen just as soon as the FDA asked for an upgraded warning on Gardasil package inserts, drily explaining that an awful lot of girls seem to be fainting after their HPV vaccinations, and wouldn’t it be rather a good idea to monitor them and make them sit down. What with the possibility of suffering grievous injuries and all.

Well, duh.

But right on cue, here come the usually male-generated media and blog comments about how teenage girls faint all over the place anyway. Couldn’t possibly because of this particular vaccine. Here’s a typical comment:

“Now ask yourself: If you line up a bunch of giddy 13-year-old girls for an injection that has something to do with sex, cancer and genital warts, would you expect more or fewer than 2 in 10,000 to faint during the process?” The writer goes on to jokingly (one assumes) wonder whether Gardasil isn’t actually preventing mass fainting.

I don’t think I’ve heard a man wonder out loud whether the mention of sex—faugh, Sir!—wouldn’t make a woman faint since I read a cartload of 19th century novels in college a few decades ago.

Can there really be people out there who are unaware that the average 13-year old (and indeed the average 11 or 12 year old) is not only quite au fait with the oh-so-shivery idea of sex but, sadly, might even be quite practiced in the art of doing various unspeakable things? And that these kids have obligingly held out their arms to get stuck many, many times since infancy, usually without even asking what the damn needle is for?

Trust me, that’s not why they’re fainting. Even Merck is prepared to admit that the genetically-engineered ‘virus-like particles’ (VLPs) in this novel type of vaccine might have something to do with both the fainting and with the more severe and longer-lasting pain associated with Gardasil.

My own 16-year old has an almost pathological fear of needles. My ultimate threat when she breaks curfew is an acupuncture appointment (I know, but it’ll give her lots to talk about when she’s in therapy later). As a six year-old she actually bit the doctor who tried to give her an MMR booster, and last year literally back backed away like a startled horse over a truly fearsome shot being given her in preparation for a trip to India.

But she has never, not once, come even remotely close to fainting.

I’ll grant you that adolescent girls are more likely to be on faint-worthy crash diets than toddlers, so let’s look at the numbers reported to VAERS, the notoriously fallible vaccine adverse event reporting system. We’ll compare them to the numbers for Menactra, since it’s given to roughly the same crash-dieting teenage crowd.

2,172 girls have suffered syncope after being given the Gardasil vaccine. Out of 463 teens who’ve suffered syncope after the Menactra vaccine, 389 were girls and 6 sex unknown.

So roughly five and a half times as many girls have fainted after receiving the Gardasil vaccine as after Menactra, and Menactra has been on offer for about a year and a half longer than Gardasil, which went on sale in 2006, and is routinely given to both boys and girls. (Compare that to the chicken pox vaccine, part of vaccination programs for both sexes since 1995, with a total of 312 cases of post-vaccination syncope.)

Now you can merge those figures statistically into the population until they’re not there anymore. Even 2,172 cases are a blip among the millions of doses administered.

Or you can join the airheads who say, “FGS, would you rather your kid had cervical cancer than risk fainting? Mine will get the shot even if they’re laid out on the floor!” Totally ignoring, of course, the fact that it’s not an either/or choice and that a) the risk of cervical cancer is tiny b) Gardasil is only 17-45 percent effective in preventing pre-cancerous cells c) fainting isn’t the only potential side-effect and could be the sign of something else going on.

But I’d have a lot more respect for Merck, the CDC, the FDA, and yes, those bloggers, if they said, hang on. It’s probably nothing, but if over five times as many kids are fainting, shouldn’t we check it out? Is this the canary in the coal mine? Could VLPs, never before used, be having an effect we really know nothing about?

Saturday, February 7, 2009

Comparing Side Effects from Gardasil and Menactra

Share
News reports about Gardasil have focused on an increasing number of formerly healthy, active girls who have suffered inexplicable weakness, paralysis and other devastating health downturns after receiving the vaccine. There is not always a clear causal connection, but girls like Ashley Ryburn, Gabby Swank, Christina Tarsell, and Jenny Tetlock put a face on what may be the dark side of the vaccine.

Now the National Vaccine Information Center has taken a more statistics-based look at the total side effects and adverse events reported to VAERS for two recommended vaccines, Menactra and Gardasil.

Both vaccines are aimed at the same population of 11-12 year-olds through college-aged kids.

Menactra, approved in early 2005 for preventing meningitis, is approved for both males and females up to the age of 55 but is mostly used for the young crowded-living crowd. It has not been marketed nearly as aggressively as Gardasil. Gardasil, of course, was launched with a very controversial and effective sales campaign in mid-2006 as a preventative for HPV, but is so far approved for use in young girls only.

As studies go, this one is flawed, although in general it isn’t unreasonable to consider a comparison. It provides no information about how many people actually received the vaccine, and a per-dose analysis, if available, would be somewhat fallacious given that Menactra is a one-dose vaccine and Gardasil is a three-dose vaccine, with some people potentially not returning for the second or third shots. * See end of post for update from NVIC.

But that’s no reason not to cast at least a jaundiced eye over the comparison.

NVIC reports that Gardasil is associated with twice as many emergency room visits, four times as many death reports, five times more ‘did not recover’ reports, and seven times more ‘disabled’ reports.

There were also 23 reports of blood clots with Gardasil and none with Menactra. However, given that rightly or wrongly the FDA has put almost all the blood clot reports down to birth control pills, and Menactra is also approved for boys (not usually too fond of taking the Pill except as a hazing ritual), this one isn’t exactly a slam dunk.

57 kids who got the Gardasil shot alone developed arthritis, compared to six who got it with the Menactra shot, and 12 who got Menactra alone or with another vaccine.

Gardasil takers suffered four times as many cardiac arrests, four times the number of cases of Lupus, 15 times the number of strokes, and 34 times the number of thrombosis. Etcetera, etcetera. For the full report, and for the full details of how often the two vaccinations were given together, go to nvic.org.

All this, alas, would be far more meaningful with the addition of an accurate count of those who received each vaccine.

One also has to consider that VAERS, the Vaccine Adverse Event Reporting System, is prey to both under-reporting and over-reporting. Under-reporting occurs when no-one connects the dots, or a doctor dismisses a patient’s concerns, or flat out doesn’t bother. It is estimated that at least 90% of adverse events and side effects go unreported.

On the other hand, over-reporting occurs when people connect the dots wrongly and simply blame a kitchen sink of symptoms on a vaccine. Gardasil, with its aggressive approval and marketing campaign, has made itself particularly vulnerable to this.

The CDC continues to recommend Gardasil, saying that it is safe and effective and that its benefits outweigh its risks; and it of course is still monitoring the situation.

NVIC is a national non-profit educational foundation that was founded by the parents of children who have been damaged by vaccines. Although it opposes only mandatory vaccination, not vaccination in general, it encourages parents to make informed choices and lobbies for increased safety.

*A researcher from NVIC sent the following comment:

"according to the sources below, the two vaccines were licensed about a year apart and about the same number of doses of each vaccine have been sold. But, because Gardasil is a three-dose series, there are probably about three times more people who received Menactra than Gardasil. So, the fact that a much larger number of serious adverse reactions were reported for Gardasil than Menactra suggests that there's a serious problem related to the reactogenicity and safety of Gardasil.Gardasil: 16 million doses in US distributed as of June 30, 2008: http://www.cdc.gov/vaccinesafety/vaers/FDA_and_CDC_Statement.htmMenactra: 15 million doses in US distributed as of February 26, 2008: http://www.cdc.gov/vaccinesafety/concerns/gbsfactsheet.htmSo, if Gardasil was no more reactive than Menactra then we would expect the number of adverse event reports to be about 1/3 of what was reported for Menactra. It's the exact opposite and then some."

Do you have any experience of either of these vaccines? If so, have you experienced any side effects or adverse advents, and have you reported them to VAERS or another drug rating mechanism? Do you see any value to the Gardasil-Menactra comparison?